Mouse Model Shows The Role Of Cell Signalling In Growth Of Cervical Cancer
Main Category: Cervical Cancer / HPV VaccineAlso Included In: Cancer / Oncology; Women's Health / Gynecology
Article Date: 29 Jan 2008 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Cervical cancer is one of the most prevalent cancers in women worldwide and is the leading cause of cancer death for women in developing countries. In research published in this week's PLoS Medicine, Douglas Hanahan (University of California San Francisco, USA) and colleagues investigate how cell signalling in the stroma - the tissue that surrounds a tumour - plays a role in the progression of cervical cancer. Using a mouse model of cervical cancer, the researchers looked at a protein that is made by the tumor cells known as platelet-derived growth factor (PDGF). The research finds that the signaling in the stromal cells triggered by the release of this protein stimulates the growth of the tumor.
In a separate perspective article, Rakesh Jain (Harvard Medical School, USA) and colleagues, who were not involved in the study, suggest that the results offer a "foundation for development of new approaches to the treatment of cervical cancer" that target PDGF signaling to slow the progression of the disease.
Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting
Pietras K, Pahler J, Bergers G, Hanahan D
PLoS Med 5(1): e19.
Click here to view article online
About PLoS Medicine
PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues.
PLoS Medicine
About the Public Library of Science
The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource.
Public Library of Science
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/95038.php>
APA
http://www.medicalnewstoday.com/releases/95038.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



